The newest Access to Medicine Index, which ranks pharmaceutical companies on their efforts to improve access to medicine in developing countries, shows that the industry, led by
GlaxoSmithKline, is doing more than critics claim.

The Access to Medicine Index is an independent initiative that provides insight into what the world’s leading pharmaceutical companies are doing for the millions of people in developing countries who do not have reliable access to safe, effective and affordable medicines, vaccines and other health-related technologies. It is published every two years.

read more

via Science 2.0 Read More…